Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
Open Access
- 1 June 2013
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 63 (2) , 228-233
Abstract
Background: Determinants of Kaposi sarcoma–associated herpesvirus (KSHV) seropositivity among children living in sub-Saharan African populations where infection is endemic are not well understood. Local environmental factors, including other infectious agents, may be key. Methods: Within the context of a well-characterized birth cohort, we examined associations between various factors and antibodies against KSHV, measured in stored plasma samples from 1823 mother–child pairs in Entebbe, Uganda. Results: Seroprevalence increased with increasing age of the child (P = 0.0003) and was higher among those with KSHV seropositive mothers than in those without (12% vs 9%; odds ratio: 1.4, 95% confidence interval: 1.1 to 2.0). It was also higher among children with HIV infection (29% vs 10%; odds ratio: 3.1, 95% confidence interval: 1.2 to 8.3) or malaria parasitemia (30% vs 10%; odds ratio: 4.1, 95% confidence interval: 2.4 to 7.0) than in children without. These associations were not explained by socioeconomic status. Conclusions: The finding that KSHV serostatus is associated with malaria parasitemia in children is novel. In a country endemic for KSHV, malaria may be a cofactor for KSHV infection or reactivation among children.Keywords
This publication has 33 references indexed in Scilit:
- Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan womenInfectious Agents and Cancer, 2011
- Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trialThe Lancet, 2011
- Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: A new approach using K8.1 ELISA and a newly developed recombinant LANA ELISAJournal of Immunological Methods, 2010
- Substantial regional differences in human herpesvirus 8 seroprevalence in sub‐Saharan Africa: Insights on the origin of the “Kaposi's sarcoma belt”International Journal of Cancer, 2010
- Children with endemic Burkitt lymphoma are deficient in EBNA1‐specific IFN‐γ T cell responsesInternational Journal of Cancer, 2009
- Parasite immunomodulation and polymorphisms of the immune systemJournal of Biology, 2009
- Associations between mild-to-moderate anaemia in pregnancy and helminth, malaria and HIV infection in Entebbe, UgandaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447]Clinical Trials, 2007
- Distribution of Kaposi Sarcoma–Associated Herpesvirus/Human Herpesvirus 8 in Maternal Saliva and Breast Milk in Zambia: Implications for TransmissionThe Journal of Infectious Diseases, 2004
- Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescentsInternational Journal of Cancer, 1998